Skip to content
X-Chem
  • About
    • Who We Are
    • How We Work
    • History
    • Executive Management
  • Technology
    • ArtemisAI
    • DEL Overview
    • DEL Track Record
  • Services
    • Services Overview
    • DEL Screening
      • DELability
      • DELflex
      • DELcore
      • DELvalent
      • DELenable
    • Medicinal Chemistry
    • Custom Synthesis
  • Products
    • Products Overview
    • ReadiDEL
    • ReadiBLOCKs
    • ReadiCOMPOUNDs
  • XD3 Solutions
  • Resources
    • Blog
    • Resource Center
    • Virtual Venue
    • Press Releases
  • Careers
    • Why X‑Chem
    • Job Opportunities
    • Students & Grads
  • Contact Us

Case Study

Case Study

X‑Chem’s Search for BRD4 Inhibitors Shows Our Ability to Drive New Discovery

September 22, 2021

Case Study

Discovering Autotaxin Inhibitors Using DNA-Encoded Libraries for the Treatment of Idiopathic Pulmonary Fibrosis

September 10, 2021

Small Molecules Hold Exponential Possibilities Find Your Next Drug Candidate With X-Chem

Talk To Us

© 2023 X-Chem. All Rights Reserved.

  • About
  • Contact Us
  • Privacy Policy
  • About
    • Who We Are
    • How We Work
    • History
    • Executive Management
  • Technology
    • ArtemisAI
    • DEL Overview
    • DEL Track Record
  • Services
    • Services Overview
    • DEL Screening
      • DELability
      • DELflex
      • DELcore
      • DELvalent
      • DELenable
    • Medicinal Chemistry
    • Custom Synthesis
  • Products
    • Products Overview
    • ReadiDEL
    • ReadiBLOCKs
    • ReadiCOMPOUNDs
  • XD3 Solutions
  • Resources
    • Blog
    • Resource Center
    • Virtual Venue
    • Press Releases
  • Careers
    • Why X‑Chem
    • Job Opportunities
    • Students & Grads
  • Contact Us